According to the latest report by IMARC Group, titled “Biosurgery Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2022-2027,” the market to reach US$ 18.2 Billion by 2027, exhibiting a CAGR of 6.95% during 2022-2027.
Biosurgery is a medical procedure that uses natural, synthetic, or semi-synthetic materials to seal surgical incisions and wounds. It is extensively utilized to prevent excessive blood loss, provide adhesion for wound or tissue sealing, repair damaged bones and tissues, etc. Biosurgeries are generally conducted through hemostatic, sealant, bone graft substitute, adhesion prevention, soft tissue repair, and staple line reinforcement products. They also use natural allografts, xenografts, and cultured epithelial autografts to minimize intra- and post-operative complications and promote faster recovery of patients. Consequently, biosurgical processes are widely adopted in several surgeries, including neurological, orthopedic, spinal, reconstruction, thoracic, cardiovascular, etc.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Biosurgery Market Trends:
The escalating incidences of musculoskeletal disorders are primarily driving the biosurgery market. Moreover, the expanding geriatric population, who are more prone to chronic medical ailments, such as osteoporosis, is further catalyzing the market growth. Besides this, numerous healthcare providers are increasingly adopting biosurgeries for effectively managing blood loss in patients with surgical sealants and minimally invasive (MI) hemostatic agents instead of conventionally used sutures and staples. This, in turn, is acting as another significant growth-inducing factor. Furthermore, the growing incidences of sports-related injuries and accidental traumas are also augmenting the global market. Apart from this, the development of plasma-based, multi-functional, and multi-use products for these surgical processes is anticipated to stimulate the biosurgery market in the coming years.
Request Free Sample Report: https://www.imarcgroup.com/biosurgery-market/requestsample
Biosurgery Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, CryoLife Inc., CSL Limited, Hemostasis LLC, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Sanofi S.A., Smith & Nephew plc, Stryker Corporation and Surgalign Spine Technologies Inc.
The report has segmented the market on the basis on region, product, source, application, end user.
Breakup by Product:
- Bone-Graft Substitutes
- Soft-Tissue Attachments
- Hemostatic Agents
- Surgical Sealants and Adhesives
- Adhesion Barriers
- Staple Line Reinforcement
Breakup by Source:
- Natural/Biologics Products
- Synthetic Products
Breakup by Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Others
Breakup by End User:
- Hospitals
- Clinics
- Others
Breakup by Region:
- North America:(United States, Canada
- Asia-Pacific:(China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America:(Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/biosurgery-market
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
